We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
+$159M
Cap. Flow
+$27.9M
Cap. Flow %
1.48%
Top 10 Hldgs %
34.09%
Holding
355
New
45
Increased
117
Reduced
138
Closed
28

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$36.2M
2
WST icon
West Pharmaceutical
WST
+$24.3M
3
NVST icon
Envista
NVST
+$23.9M
4
JPM icon
JPMorgan Chase
JPM
+$22.1M
5
ETN icon
Eaton
ETN
+$15.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23.5M
2
ALL icon
Allstate
ALL
+$22.6M
3
CDNS icon
Cadence Design Systems
CDNS
+$21.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$20.7M
5
ZBRA icon
Zebra Technologies
ZBRA
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 30.41%
2 Consumer Discretionary 14.8%
3 Healthcare 14.63%
4 Financials 11.82%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
276
Cisco
CSCO
$483B
$8K ﹤0.01%
146
– –
DUK icon
277
Duke Energy
DUK
$94.5B
$8K ﹤0.01%
81
– –
FTI icon
278
TechnipFMC
FTI
$29.1B
$8K ﹤0.01%
1,010
-132
-12% -$1.08K
ICE icon
279
Intercontinental Exchange
ICE
$84.5B
$8K ﹤0.01%
75
+7
+10% +$794
MRSH
280
Marsh
MRSH
$91B
$8K ﹤0.01%
66
+6
+10% +$691
NTRA icon
281
Natera
NTRA
$45.9B
$8K ﹤0.01%
80
-2,090
-96% -$229K
RARE icon
282
Ultragenyx Pharmaceutical
RARE
$2.64B
$8K ﹤0.01%
70
-1,890
-96% -$257K
SO icon
283
Southern Company
SO
$105B
$8K ﹤0.01%
128
– –
VZ icon
284
Verizon
VZ
$195B
$8K ﹤0.01%
129
– –
AON icon
285
Aon
AON
$75.7B
$7K ﹤0.01%
32
+3
+10% +$660
ARWR icon
286
Arrowhead Research
ARWR
$12.5B
$7K ﹤0.01%
110
-3,190
-97% -$248K
BPMC
287
DELISTED
Blueprint Medicines
BPMC
$7K ﹤0.01%
70
-1,790
-96% -$179K
BTG icon
288
B2Gold
BTG
$6.68B
$7K ﹤0.01%
1,550
+210
+16% +$1.02K
FATE icon
289
Fate Therapeutics
FATE
$322M
$7K ﹤0.01%
90
-2,490
-97% -$239K
GIS icon
290
General Mills
GIS
$19.9B
$7K ﹤0.01%
108
– –
KMB icon
291
Kimberly-Clark
KMB
$35.9B
$7K ﹤0.01%
47
– –
MCO icon
292
Moody's
MCO
$82.8B
$7K ﹤0.01%
25
+3
+14% +$845
SANM icon
293
Sanmina
SANM
$10.7B
$7K ﹤0.01%
160
-4,180
-96% -$152K
VALE icon
294
Vale
VALE
$63.4B
$7K ﹤0.01%
380
+50
+15% +$873
BBIO icon
295
BridgeBio Pharma
BBIO
$16.6B
$6K ﹤0.01%
100
-2,890
-97% -$189K
CLX icon
296
Clorox
CLX
$13B
$6K ﹤0.01%
30
– –
HALO icon
297
Halozyme
HALO
$12.2B
$6K ﹤0.01%
150
-4,290
-97% -$196K
HSTM icon
298
HealthStream
HSTM
$859M
$6K ﹤0.01%
270
-7,670
-97% -$183K
KBH icon
299
KB Home
KBH
$3.47B
$6K ﹤0.01%
130
-3,790
-97% -$157K
MGY icon
300
Magnolia Oil & Gas
MGY
$6.16B
$6K ﹤0.01%
+520
New +$5.42K
10 11
12
13 14

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Smith Group Asset Management held 355 positions worth $1.89B, up 9.2% from $1.73B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Smith Group Asset Management's Q1 2021 filing shows 45 new, 117 increased, 138 reduced and 28 closed positions. Its largest new stake was West Pharmaceutical: 84,965 shares worth $24M. The largest sale was Apple, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Smith Group Asset Management's largest Q1 2021 buy was West Pharmaceutical: 84,965 shares worth $24M.
  • Smith Group Asset Management added most to Capital One in Q1 2021, an estimated $36.2M increase.
  • Smith Group Asset Management's biggest Q1 2021 reduction was Apple, cutting an estimated $23.5M.
  • Smith Group Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021, selling an estimated $20.7M.
  • Smith Group Asset Management's ten largest holdings make up 34% of its $1.89B portfolio in Q1 2021.
  • Smith Group Asset Management opened 45 new positions and closed 28 in Q1 2021.
  • Smith Group Asset Management's portfolio value rose 9.2% quarter-over-quarter to $1.89B.

Based on Smith Group Asset Management's 13F filing for Q1 2021, filed 7 May 2021.